Role of immunotherapy in triple-negative breast cancer
TE Keenan, SM Tolaney - Journal of the National Comprehensive Cancer …, 2020 - jnccn.org
Immune checkpoint inhibitors (ICIs) have led to durable clinical remissions in many
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
Role of Immunotherapy in Triple-Negative Breast Cancer.
TE Keenan, SM Tolaney - Journal of the National Comprehensive …, 2020 - europepmc.org
Immune checkpoint inhibitors (ICIs) have led to durable clinical remissions in many
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
Role of Immunotherapy in Triple-Negative Breast Cancer
TE Keenan, SM Tolaney - Journal of the National …, 2020 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) have led to durable clinical remissions in many
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
Role of Immunotherapy in Triple-Negative Breast Cancer
TE Keenan, SM Tolaney - Journal of the National Comprehensive …, 2020 - cir.nii.ac.jp
抄録< jats: p> Immune checkpoint inhibitors (ICIs) have led to durable clinical remissions in
many metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
many metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
Role of Immunotherapy in Triple-Negative Breast Cancer
TE Keenan, SM Tolaney - Journal of the National Comprehensive Cancer …, 2020 - jnccn.org
Immune checkpoint inhibitors (ICIs) have led to durable clinical remissions in many
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …
metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low …